Sumiyuki Nishida

4PUBLICATIONS
18CO-AUTHORS
Haematological tumoursImmunogenetics (incl. genetic immunology)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 17, 2026
WT1 peptide vaccines of post-allogeneic HSCT maintenance immunotherapy for pediatric acute leukemias: a phase II study.

|May 18, 2026
Immunopathophysiology of immune checkpoint inhibitor-related pneumonitis: insights from multi-omics and immune profiling.

|Jan 21, 2023
WT1 Trio Peptide-Based Cancer Vaccine for Rare Cancers Expressing Shared Target WT1.

Yusuke Oji, Naoki Kagawa, Hideyuki Arita

|Jul 07, 2022
CpG ODN (K3)-toll-like receptor 9 agonist-induces Th1-type immune response and enhances cytotoxic activity in advanced lung cancer patients: a phase I study.

Tomoyuki Otsuka, Sumiyuki Nishida, Takayuki Shibahara

Pageof 1

Frequent Collaborators

2 joint publications

Jun Nakata

1 joint publications

Yusuke Oji

1 joint publications

Hidetatsu Outani

1 joint publications

Yasushi Shintani